Medications for Hypersexuality Management
Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacological treatment for hypersexuality, with paroxetine, sertraline, fluoxetine, and citalopram showing efficacy in reducing excessive sexual behaviors. 1
Pharmacological Treatment Options
First-Line Medications
- SSRIs:
- Paroxetine: 10-40 mg daily
- Sertraline: 25-200 mg daily
- Fluoxetine: 5-20 mg daily
- Citalopram: 10-40 mg daily
These medications work by increasing serotonin levels, which helps reduce sexual drive and compulsivity. They can be administered either daily or on-demand (particularly for paroxetine 20 mg taken 3-4 hours before anticipated sexual activity) 1.
Second-Line Medications
Tricyclic Antidepressants:
- Clomipramine: 25-50 mg daily or 25 mg taken 4-24 hours before anticipated sexual activity 1
Hormonal Agents (for severe cases):
- Medroxyprogesterone acetate (injectable): Used for prevention of pregnancy but has off-label use for hypersexuality due to its effect on reducing sexual drive 2
Assessment Before Treatment
Before initiating medication:
Determine if hypersexuality is primary or secondary:
Evaluate testosterone levels in male patients:
- Morning testosterone <300 ng/dL may indicate hypogonadism, which could affect treatment approach 1
Screen for contraindications:
- Cardiac conditions that may interact with medications
- Current use of nitrates (contraindicated with PDE5 inhibitors if ED is also present) 5
Treatment Algorithm
Start with SSRIs as first-line treatment:
- Begin with lower doses and titrate as needed
- Monitor for efficacy and side effects
- Allow 2-4 weeks for full therapeutic effect
If inadequate response to SSRIs:
- Consider switching to another SSRI
- Add clomipramine as an alternative or adjunct
- Consider hormonal therapy for severe, treatment-resistant cases
For situational hypersexuality:
- Consider on-demand dosing of paroxetine (20 mg, 3-4 hours before anticipated sexual activity) or
- Clomipramine (25 mg, 4-24 hours before anticipated sexual activity) 1
Monitoring and Follow-up
- Assess response to treatment at 4-6 week intervals
- Monitor for side effects, particularly:
Important Considerations
- Medication alone is often insufficient - consider concurrent psychotherapy or sexual counseling 4
- Caution with tramadol - while it may help reduce hypersexuality through opioid receptor activation and serotonin/noradrenaline reuptake inhibition, it has addiction potential and limited long-term safety data 1
- For patients with comorbid erectile dysfunction, PDE5 inhibitors can be used alongside SSRIs but may potentially worsen hypersexuality symptoms in some cases 1
Special Populations
- Cognitively impaired older adults: Lower doses of SSRIs are typically recommended with careful monitoring for side effects 7
- Patients with bipolar disorder: Mood stabilizers should be the primary treatment, with SSRIs added cautiously to avoid triggering manic episodes 3
By following this structured approach to medication management for hypersexuality, clinicians can effectively address this challenging condition while minimizing risks and optimizing outcomes for patients.